resveratrol has been researched along with Melanoma in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (26.53) | 29.6817 |
| 2010's | 27 (55.10) | 24.3611 |
| 2020's | 9 (18.37) | 2.80 |
| Authors | Studies |
|---|---|
| Andrus, MB; Brewer, KI; Osmond, G; Tyler, DS; Wong, Y | 1 |
| Haudecoeur, R; Pérès, B; Roulier, B | 1 |
| Dagli, MLZ; Fukuoka, N; Ishida, T; Ishii, K; Sato, A; Virgona, N; Yano, T | 1 |
| Batista, FPR; Cilli, EM; Colauto, NB; de Cerqueira E Silva, MB; de Grandis, RA; de Souza, ML; Dourado, D; Ferreira, ES; Formiga, FR; Miranda, PA; Oliveira de Souza, C; Pavan, FR; Pereira, DT; Philadelpho, BO | 1 |
| Fil, D; Garg, S; Heflin, B; Koss, B; Miousse, IR; Morehead, LC; Tackett, AJ; Wallis, KF | 1 |
| Abbaszadeh-Goudarzi, K; Asemi, Z; Goodarzi, M; Hajighadimi, S; Mirzaei, H; Moradizarmehri, S; Piccirillo, SGM; Pourhanifeh, MH; Shafiee, A | 1 |
| Chen, W; Chen, X; Li, F; Su, J; Tang, L; Wu, L; Zhao, S | 1 |
| Emri, G; Fidrus, E; Hegedűs, C; Janka, EA; Paragh, G; Remenyik, É | 1 |
| Alnasser, MHA; Chauhan, H; Ekpenyong, A; Hussein, N; Mimlitz, M; Palliyage, GH; Singh, S; Tiwari, AK; Weeder, C | 1 |
| Chillà, A; Del Rosso, M; Fibbi, G; Giovannelli, L; Laurenzana, A; Margheri, F; Menicacci, B; Mocali, A; Peppicelli, S; Tanganelli, E | 1 |
| Aquino, A; Bonmassar, E; Bonmassar, L; Fuggetta, MP; Guida, S; Montesarchio, D; Musumeci, D; Platella, C; Ravagnan, G; Roviello, GN | 1 |
| Dong, Y; Lei, MJ; Sun, CX; Zhang, XH | 1 |
| Cui, L; Wu, F | 1 |
| Borie, N; Clément, C; Courot, E; Delmas, D; Harakat, D; Hubert, J; Jeandet, P; Martiny, L; Nivelle, L; Nuzillard, JM; Renault, JH; Tarpin, M | 1 |
| Aires, V; Delmas, D; Martiny, L; Nivelle, L; Rioult, D; Tarpin, M | 1 |
| Choi, KC; Heo, JR; Hwang, KA; Kang, JH; Kim, SM | 1 |
| Chen, D; Chen, X; Hua, Z; Huang, Q; Lee, YM; Li, W; Lin, Q; Shen, P; Sheng, J; Tan, R; Wang, J; Wong, YK; Xu, C; Zhu, B; Zou, Y | 1 |
| Bachelot, L; Bessede, A; Boussemart, L; Corre, S; Denison, MS; Dumontet, E; Galibert, MD; Gautron, A; Gilot, D; Guillemin, GJ; Leclair, HM; Marine, JC; Mouchet, N; Perrot, A; Rambow, F; Rogiers, A; Soshilov, A; Tardif, N; Tarte, K | 1 |
| Choi, HR; Kwon, SH; Na, JI; Park, KC; Shin, JW | 1 |
| Ansary, J; Battino, M; Chen, R; Cianciosi, D; Forbes-Hernandez, TY; Giampieri, F; Gil, E; Liu, S; Yang, HZ; Zeng, J; Zhang, F; Zhang, J; Zhou, F | 1 |
| Ashby, CR; Chauhan, H; Heenatigala Palliyage, G; Singh, S; Tiwari, AK | 1 |
| Katariya, M; Patil, S; Pillai, R; Ravikumar, P; Tatke, P | 1 |
| Bradley, MJ; Cook, KM; Fang, Y; Herrick, EJ; Nicholl, MB | 1 |
| Bajek, A; Czajkowski, R; Drewa, T; Schwartz, RA; Uzarska, M; Zegarska, B | 1 |
| Tong, LX; Young, LC | 1 |
| Abdelhamed, S; Awale, S; Hayakawa, Y; Saiki, I; Sakurai, H; Yokoyama, S | 1 |
| Chen, N; Chen, R; E, C; Liu, B; Liu, J; Wu, Z; Zhang, Q; Zhu, R | 1 |
| Manna, SK; Mokhamatam, RB; Sahoo, BK | 1 |
| Doi, K; Luo, H; Morisaki, T; Shirasawa, S; Tsunoda, T; Umebayashi, M | 1 |
| Chiu, R; Liu, F; Meyskens, FL; Misner, BJ; Yang, S; Yang, Z | 1 |
| Augustine, CK; Osmond, GW; Padussis, J; Tyler, DS; Zipfel, PA | 1 |
| Fruehauf, JP; Papazian, V; Parmakhtiar, B; Trapp, V; Willmott, L | 1 |
| Egilegor, E; Gallot, N; Mendoza, L; Olaso, E; Salado, C; Valcarcel, M; Vidal-Vanaclocha, F | 1 |
| Kim, MY | 1 |
| Chang, WW; Chen, MC; Hsu, HC; Kuan, YD; Lee, CH; Lin, ST | 1 |
| Freedland, SJ; Masko, EM; Osmond, GW; Pizzo, S; Tyler, DS | 1 |
| Guan, H; Nagarkatti, M; Nagarkatti, PS; Singh, NP; Singh, UP | 1 |
| Fu, YM; McFarland, M; Meadows, GG; Niles, RM; Redkar, A; Weimer, MB | 1 |
| Espín, JC; Larrosa, M; Tomás-Barberán, FA | 1 |
| Debatin, KM; Fulda, S | 1 |
| Cannavò, E; D'Atri, S; Falchetti, R; Fuggetta, MP; Lanzilli, G; Ravagnan, G; Tricarico, M; Zambruno, G | 1 |
| Meyskens, FL; Yang, S | 1 |
| Hamby, CV; Hsieh, TC; Wang, Z; Wu, JM | 1 |
| Heffron, SE; Irani, K; Jurnak, F; Meyskens, FL; Yang, S | 1 |
| Cook, CP; Fu, YM; McLaughlin, JL; Meadows, GG; Niles, RM; Rankin, GO | 1 |
| Baryshnikov, AY; Burova, OS; Lichinitser, MR; Stepanova, EV; Vartanian, AA | 1 |
| Hei, TK; Huang, SX; Ivanov, VN; Johnson, GE; Partridge, MA; Zhou, H | 1 |
| Albert, DM; Bhattacharya, S; Darjatmoko, SR; Lindstrom, MJ; Polans, AS; Sareen, D; Subramanian, L; van Ginkel, PR | 1 |
| Hei, TK; Ivanov, VN; Johnson, GE | 1 |
5 review(s) available for resveratrol and Melanoma
| Article | Year |
|---|---|
Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.
Topics: Agaricales; Amino Acid Sequence; Biological Factors; Drug Delivery Systems; Drug Design; Enzyme Inhibitors; Humans; Melanins; Melanocytes; Melanoma; Monophenol Monooxygenase; Pigmentation; Protein Structure, Secondary; Skin Lightening Preparations | 2020 |
Resveratrol as a Multifunctional Topical Hypopigmenting Agent.
Topics: Administration, Topical; Animals; Humans; Hypopigmentation; Keratinocytes; Melanocytes; Melanoma; Resveratrol | 2019 |
Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols: Potential Role in Prevention and Treatment of Melanoma.
Topics: Animals; Antioxidants; Biological Availability; Catechin; Curcumin; Drug Delivery Systems; Humans; Melanoma; Nanoparticles; Polyphenols; Quercetin; Resveratrol; Skin Neoplasms; Solubility | 2019 |
Chemoprevention of skin melanoma: facts and myths.
Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Cell Line, Tumor; Cell Transformation, Neoplastic; Chemoprevention; Curcumin; Flavonoids; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Pigmentation; Randomized Controlled Trials as Topic; Resveratrol; Retinoids; Risk; Skin; Skin Neoplasms; Stilbenes; Tea; Treatment Outcome; Vitamin D | 2013 |
Nutrition: the future of melanoma prevention?
Topics: Antioxidants; Carotenoids; Catechin; Diet; Grape Seed Extract; Humans; Lycopene; Melanoma; Nutrition Policy; Proanthocyanidins; Resveratrol; Selenium; Skin Neoplasms; Stilbenes; Vitamin D; Vitamin E | 2014 |
44 other study(ies) available for resveratrol and Melanoma
| Article | Year |
|---|---|
Synthesis of 4'-ester analogs of resveratrol and their evaluation in malignant melanoma and pancreatic cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Esters; HL-60 Cells; Humans; Melanoma; Pancreatic Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship | 2010 |
Resveratrol can induce differentiating phenotypes in canine oral mucosal melanoma cells.
Topics: Animals; Dog Diseases; Dogs; MAP Kinase Signaling System; Melanoma; Mitogen-Activated Protein Kinases; Resveratrol; RNA, Messenger | 2023 |
Resveratrol-Loaded
Topics: Antineoplastic Agents; Drug Carriers; Humans; Melanoma; Nanoparticles; Particle Size; Plant Oils; Resveratrol | 2023 |
Resveratrol induces major histocompatibility complex class I antigen presentation in a STING-dependent and independent manner in melanoma.
Topics: Antigen Presentation; Antigens, Neoplasm; Histocompatibility Antigens Class I; HLA Antigens; Humans; Interferons; Major Histocompatibility Complex; Melanoma; Proteomics; Resveratrol | 2023 |
Resveratrol: A New Potential Therapeutic Agent for Melanoma?
Topics: Apoptosis; Humans; Melanoma; Quality of Life; Resveratrol; Skin Neoplasms; Stilbenes | 2021 |
Resveratrol-induced apoptosis is associated with regulating the miR-492/CD147 pathway in malignant melanoma cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Basigin; Cell Line, Tumor; Humans; Melanoma; MicroRNAs; Poly(ADP-ribose) Polymerases; Resveratrol; Signal Transduction; Up-Regulation | 2021 |
Inhibitors of Nucleotide Excision Repair Decrease UVB-Induced Mutagenesis-An In Vitro Study.
Topics: Animals; Arsenic Trioxide; Autophagy; Benzimidazoles; Cell Cycle Checkpoints; Cell Line, Transformed; Cell Survival; CHO Cells; Cricetulus; DNA Damage; DNA Repair; HaCaT Cells; Humans; Hypoxanthine Phosphoribosyltransferase; Melanoma; Mutation Rate; Pyrimidine Dimers; Resveratrol; Skin; Skin Neoplasms; Spironolactone; Ultraviolet Rays | 2021 |
Novel Curcumin-Resveratrol Solid Nanoparticles Synergistically Inhibit Proliferation of Melanoma Cells.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Curcumin; Drug Carriers; Drug Combinations; Drug Liberation; Humans; Lipids; Melanoma; Mice; Nanoparticles; Particle Size; Permeability; Resveratrol; Skin; Skin Neoplasms; Snakes | 2021 |
Chronic Resveratrol Treatment Inhibits MRC5 Fibroblast SASP-Related Protumoral Effects on Melanoma Cells.
Topics: Animals; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Culture Media, Conditioned; Fibroblasts; Humans; Interleukins; Melanoma; Mice; Phenotype; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes; Tumor Cells, Cultured; Tumor Microenvironment | 2017 |
Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase.
Topics: Antineoplastic Agents; Biophysical Phenomena; Cell Line, Tumor; Cell Proliferation; Circular Dichroism; Copper; G-Quadruplexes; Humans; Melanoma; Nucleic Acid Conformation; Resveratrol; Spectrometry, Fluorescence; Spectrum Analysis; Stilbenes; Telomerase | 2017 |
Resveratrol inhibits proliferation, promotes differentiation and melanogenesis in HT-144 melanoma cells through inhibition of MEK/ERK kinase pathway.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclic AMP Response Element-Binding Protein; Humans; MAP Kinase Signaling System; Melanins; Melanoma; Mitogen-Activated Protein Kinase 3; Resveratrol; Stilbenes | 2017 |
Resveratrol suppresses melanoma by inhibiting NF-κB/miR-221 and inducing TFG expression.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinogenesis; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Mice; Mice, SCID; MicroRNAs; Proteins; Resveratrol; Signal Transduction; Stilbenes; Transcription Factor RelA; Xenograft Model Antitumor Assays | 2017 |
Cytotoxicity of Labruscol, a New Resveratrol Dimer Produced by Grapevine Cell Suspensions, on Human Skin Melanoma Cancer Cell Line HT-144.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bioreactors; Cell Line, Tumor; Cell Survival; Dimerization; Humans; Magnetic Resonance Spectroscopy; Melanoma; Melanoma, Cutaneous Malignant; Molecular Structure; Plant Cells; Resveratrol; Skin Neoplasms; Stilbenes; Vitis | 2017 |
Molecular analysis of differential antiproliferative activity of resveratrol, epsilon viniferin and labruscol on melanoma cells and normal dermal cells.
Topics: Anticarcinogenic Agents; Benzofurans; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Fibroblasts; Humans; Melanoma; Resveratrol; S Phase; Skin; Stilbenes; Vitis | 2018 |
Resveratrol induced reactive oxygen species and endoplasmic reticulum stress‑mediated apoptosis, and cell cycle arrest in the A375SM malignant melanoma cell line.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endoplasmic Reticulum Stress; Humans; Melanoma; Melanoma, Cutaneous Malignant; Models, Biological; Reactive Oxygen Species; Resveratrol; Skin Neoplasms; Stilbenes | 2018 |
Comparative profiling of analog targets: a case study on resveratrol for mouse melanoma metastasis suppression.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Movement; Epigenesis, Genetic; Gene Expression Profiling; Melanoma; Mice, Inbred C57BL; Neoplasm Metastasis; Resveratrol; Structure-Activity Relationship | 2018 |
Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma.
Topics: Animals; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Imidazoles; MCF-7 Cells; Melanoma; Mice; Mice, SCID; Molecular Docking Simulation; Mutation; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Receptors, Aryl Hydrocarbon; Resveratrol; Skin Neoplasms; Transcription Factors; Tumor Burden; Vemurafenib; Xenograft Model Antitumor Assays | 2018 |
Resveratrol inhibits the proliferation of melanoma cells by modulating cell cycle.
Topics: Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Humans; Melanoma; Resveratrol | 2020 |
Skin delivery of resveratrol encapsulated lipidic formulation for melanoma chemoprevention.
Topics: Administration, Topical; Animals; Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Delayed-Action Preparations; Drug Liberation; Gels; Lipids; Melanoma; Mice, Inbred C57BL; Resveratrol | 2019 |
A potential role for resveratrol as a radiation sensitizer for melanoma treatment.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Cyclin D; Drug Therapy; Humans; Inhibitor of Apoptosis Proteins; Melanoma; Proto-Oncogene Proteins c-bcl-2; Radiation-Sensitizing Agents; Radiotherapy; Resveratrol; Skin Neoplasms; Stilbenes; Survivin | 2013 |
Survivin suppression through STAT3/β-catenin is essential for resveratrol-induced melanoma apoptosis.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; beta Catenin; Blotting, Western; Cell Line, Tumor; Chromatin Immunoprecipitation; Humans; Inhibitor of Apoptosis Proteins; Melanoma; Mice; Mice, Inbred C57BL; Real-Time Polymerase Chain Reaction; Resveratrol; Signal Transduction; Skin Neoplasms; STAT3 Transcription Factor; Stilbenes; Survivin; Xenograft Model Antitumor Assays | 2014 |
Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Humans; Melanoma; Resveratrol; Stilbenes | 2015 |
Suppression of microphthalmia-associated transcription factor, but not NF-kappa B sensitizes melanoma specific cell death.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Down-Regulation; HT29 Cells; Humans; Melanoma; Microphthalmia-Associated Transcription Factor; NF-kappa B; Resveratrol; S Phase; Stilbenes | 2016 |
Resveratrol Overcomes Cellular Resistance to Vemurafenib Through Dephosphorylation of AKT in BRAF-mutated Melanoma Cells.
Topics: Antineoplastic Agents; Drug Resistance, Neoplasm; Drug Synergism; Humans; Indoles; Inhibitory Concentration 50; Melanoma; Mutation, Missense; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes; Sulfonamides; Tumor Cells, Cultured; Vemurafenib | 2016 |
Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Disease Progression; DNA-(Apurinic or Apyrimidinic Site) Lyase; Feedback, Physiological; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Models, Biological; Neoplasm Metastasis; Nitric Oxide; Resveratrol; Stilbenes; Transcription Factor AP-1 | 2008 |
Enhancing melanoma treatment with resveratrol.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Chemotherapy, Adjuvant; Dacarbazine; Disease Models, Animal; Drug Therapy, Combination; Humans; In Vitro Techniques; Melanoma; Melphalan; Mice; Mice, Nude; Mice, SCID; Resveratrol; Skin Neoplasms; Stilbenes; Temozolomide; Treatment Outcome; Xenograft Model Antitumor Assays | 2012 |
Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture.
Topics: Angiogenesis Inhibitors; Cell Survival; Cells, Cultured; Coculture Techniques; Drug Evaluation, Preclinical; Endothelial Cells; Gene Expression; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Melanoma; Neovascularization, Pathologic; Protein Stability; Resveratrol; Stilbenes; Thrombospondin 1; Vascular Endothelial Growth Factor A | 2010 |
Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18.
Topics: Animals; Cell Adhesion; Cell Proliferation; Endothelium; Inflammation; Interleukin-18; Liver; Liver Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microvessels; Models, Biological; Neoplasm Transplantation; Resveratrol; Stilbenes; Tumor Microenvironment; Vascular Cell Adhesion Molecule-1 | 2011 |
Nitric oxide triggers apoptosis in A375 human melanoma cells treated with capsaicin and resveratrol.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Capsaicin; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cytochromes c; Humans; Melanoma; Mitochondria; Nitric Oxide; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53 | 2012 |
Resveratrol inhibits LPS-induced epithelial-mesenchymal transition in mouse melanoma model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Cadherins; Disease Models, Animal; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lipopolysaccharides; Male; Melanoma; Mice; Mice, Inbred C3H; NF-kappa B; Resveratrol; Signal Transduction; Skin Neoplasms; Snail Family Transcription Factors; Stilbenes; Transcription Factors | 2012 |
In vitro and in vivo evaluation of resveratrol and 3,5-dihydroxy-4'-acetoxy-trans-stilbene in the treatment of human prostate carcinoma and melanoma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Male; Melanoma; Mice; Mice, Nude; Prostatic Neoplasms; Resveratrol; Skin Neoplasms; Stilbenes; Time Factors; Treatment Outcome; Xenograft Model Antitumor Assays | 2013 |
Resveratrol prevents endothelial cells injury in high-dose interleukin-2 therapy against melanoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Endothelial Cells; Female; Immunotherapy; Interleukin-2; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Melanoma; Mice; Neoplasm Transplantation; Resveratrol; Stilbenes; T-Lymphocytes, Regulatory | 2012 |
Resveratrol is a potent inducer of apoptosis in human melanoma cells.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Division; DNA Fragmentation; Humans; MAP Kinase Signaling System; Melanoma; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2003 |
Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells.
Topics: Apoptosis; Cell Cycle; Cell Division; Cyclin A; Cyclin B; Cyclin B1; Cyclin E; Cyclins; Fruit; Humans; Melanoma; Resveratrol; S Phase; Stilbenes; Tumor Cells, Cultured; Vitis | 2003 |
Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol.
Topics: Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Base Sequence; Brain Neoplasms; Breast Neoplasms; Caspase Inhibitors; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cysteine Proteinase Inhibitors; DNA Primers; Female; Humans; Male; Melanoma; Membrane Glycoproteins; Pancreatic Neoplasms; Prostatic Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha | 2004 |
In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; Keratinocytes; Melanoma; Necrosis; Poly(ADP-ribose) Polymerases; Resveratrol; S Phase; Stilbenes; Temozolomide; Time Factors | 2004 |
Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma.
Topics: Antioxidants; Apoptosis; Cell Cycle; Cell Line; Cell Line, Tumor; Humans; Infant, Newborn; Melanocytes; Melanoma; Phenotype; Reactive Oxygen Species; Resveratrol; Stilbenes; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription, Genetic | 2005 |
Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Quinone Reductases; Resveratrol; Stilbenes; Tumor Suppressor Protein p53; Up-Regulation | 2005 |
Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor.
Topics: DNA-(Apurinic or Apyrimidinic Site) Lyase; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Fluorescent Antibody Technique; Humans; Melanocytes; Melanoma; Recombinant Proteins; Resveratrol; Stilbenes | 2005 |
Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth.
Topics: Animals; Anticarcinogenic Agents; Cell Division; Cell Line, Tumor; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Diet; Drug Implants; Humans; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Oxidation-Reduction; Resveratrol; Stilbenes; Transplantation, Heterologous | 2006 |
Melanoma vasculogenic mimicry is strongly related to reactive oxygen species level.
Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Apoptosis; Capillaries; Caspase 3; Cell Line, Tumor; Cytochromes c; Female; Humans; Melanoma; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Reactive Oxygen Species; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A | 2007 |
Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Gene Expression Regulation; Humans; Melanoma; NF-kappa B; Receptors, TNF-Related Apoptosis-Inducing Ligand; Resveratrol; STAT3 Transcription Factor; Stilbenes; TNF-Related Apoptosis-Inducing Ligand | 2008 |
Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Biological Availability; Blotting, Western; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Cytochromes c; Disease Models, Animal; Dose-Response Relationship, Drug; Intracellular Signaling Peptides and Proteins; Melanoma; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Mitochondrial Proteins; Resveratrol; Stilbenes; Transplantation, Heterologous; Uveal Neoplasms | 2008 |
Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Chromones; Combined Modality Therapy; Cyclooxygenase 2 Inhibitors; Gamma Rays; Humans; MAP Kinase Signaling System; Melanoma; Mice; Morpholines; Nitrobenzenes; Phosphoinositide-3 Kinase Inhibitors; Radiation-Sensitizing Agents; Resveratrol; RNA Interference; Signal Transduction; Stilbenes; Sulfonamides; TNF-Related Apoptosis-Inducing Ligand | 2008 |